Background illustration for clinical trials search

Paid Clinical Trials Iowa

Discover 667 paid clinical trials in Iowa. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter
1

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for
Pancreatic Neoplasm
Location: Westerly RI, Waterford CT, Guilford CT, Glastonbury CT,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funnel Catheter

for
Acute Ischemic Stroke From Large Vessel Occlusion
Location: Boston MA, New York NY, Buffalo NY, Pittsburgh PA,
Sponsor: Anaconda Biomed S.L.

Sex: All

Age: 22 - 70+

Code: NCT06370182

Recruiting

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

for
Heart Failure
Location: Quebec, Sherbrooke, New York NY, Trois-Rivieres,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06935370

Phase 3, Recruiting

Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe

for
Ischemic Stroke
Location: Pittsburgh PA, Toledo OH, Iowa City IA
Sponsor: Raul Nogueira

Sex: All

Age: 18+

Code: NCT05983757

Recruiting

A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

for
Urothelial Carcinoma Bladder,
Location: New York NY, Glen Burnie MD, Miami FL, Pittsburgh PA,
Sponsor: Aktis Oncology, Inc.

Sex: All

Age: 18+

Code: NCT07020117

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Inobrodib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma Refractory, Multiple Myeloma in Relapse
Location: Boston MA, Hackensack NJ, New Brunswick NJ,
Sponsor: CellCentric Ltd.

Sex: All

Age: 18+

Code: NCT07096778

Phase 2, Recruiting

EVERO Drug-coated Balloon (DCB) Randomized Trial

for
Peripheral Vascular Disease, Peripheral Arterial Disease
Location: New Haven CT, Camden NJ, Miami FL, Jacksonville FL,
Sponsor: Cook Research Incorporated

Sex: All

Age: 18+

Code: NCT07144150

Recruiting

SPI-1005 in Adults Receiving Cochlear Implant

for
Hearing Loss, Cochlear Trauma
Location: Philadelphia PA, Charleston SC, Columbus OH,
Sponsor: Sound Pharmaceuticals, Incorporated

Sex: All

Age: 18+

Code: NCT06340633

Phase 2, Recruiting

Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma

for
Multiple Myeloma, Newly Diagnosed, Multiple Myeloma (MM)
Location: Norfolk VA, Chapel Hill NC, Columbus OH, Birmingham AL,
Sponsor: SCRI Development Innovations, LLC

Sex: All

Age: 19+

Code: NCT06974786

Phase 2, Recruiting

Neonatal Platelet Transfusion Threshold Trial

for
Thrombocytopenia, Neonatal, Platelet Transfusion,
Location: Boston MA, Philadelphia PA, Rochester NY, Durham NC,
Sponsor: NICHD Neonatal Research Network

Sex: All

Age: 0

Code: NCT06676904

Recruiting

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for
Cardiovascular Disease
Location: Sydney, Halifax, Bridgewater, Bangor ME, Scarborough ME,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07000357

Phase 3, Recruiting

E-Mindfulness Approaches for Living After Breast Cancer

for
Breast Cancer, Depression
Location: Gloucester MA, Beverly MA, Peabody MA, Boston MA,
Sponsor: NRG Oncology

Sex: All

Age: 18 - 50

Code: NCT06748222

Phase 3, Recruiting

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

for
Prostate Cancer (Adenocarcinoma)
Location: Saint John, Providence RI, Saint Johnsbury VT,
Sponsor: Canadian Cancer Trials Group

Sex: Male

Age: 18+

Code: NCT06592924

Phase 3, Recruiting

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

for
PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC,
Location: Boston MA, New York NY, Washington D.C. DC, Fairfax VA,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06922591

Phase 1, Phase 2, Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

for
Systemic Lupus Erythematosus (With and Without Nephritis),
Location: New York NY, East Brunswick NJ, Montreal, Baltimore MD,
Sponsor: Allogene Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07085104

Phase 1, Recruiting

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Boston MA, New Haven CT, Valhalla NY, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT06941272

Phase 1, Phase 2, Recruiting

Robotic-Assisted Versus Manual Electrode Array Insertion

for
Cochlear Implantation, Robotics
Location: Iowa City IA
Sponsor: Bruce J Gantz

Sex: All

Age: 18 - 70+

Code: NCT06951594

Recruiting

Adenosine vs Diltiazem for Treatment of SVT in the ED

for
Supraventricular Tachycardia (SVT)
Location: Iowa City IA
Sponsor: Anne E. Zepeski

Sex: All

Age: 18 - 70+

Code: NCT06993038

Recruiting

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

for
Hepatitis B Virus Infection
Location: Baltimore MD, Richmond VA, Peachtree Corners GA,
Sponsor: GigaGen, Inc.

Sex: All

Age: 18+

Code: NCT07024641

Phase 1, Recruiting

A Study of Nipocalimab or Intravenous Immunoglobulin (IVIG) in Pregnancies At Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

for
Thrombocytopenia, Neonatal Alloimmune
Location: Philadelphia PA, Rochester NY, Chapel Hill NC,
Sponsor: Janssen Research & Development, LLC

Sex: Female

Age: 18 - 45

Code: NCT06533098

Phase 3, Recruiting

Popular cities in Iowa

Offering a distinguished healthcare infrastructure and top class research institutions, Iowa has emerged as a significant base for a wide range of clinical trials. Major institutions such as the University of Iowa Hospitals and Clinics and the Holden Comprehensive Cancer Center are at the forefront of these studies, driving advancements in fields like oncology, cardiovascular research, and more. Iowa’s commitment to medical innovation and its growing network of research centers make it a developing hub in cutting-edge clinical trials.

Why choose Iowa for clinical trials?

Iowa offers distinct advantages for those participating in clinical trials. The state's distinct population, combined with its strong agricultural and rural communities, provides a diverse range of participants that enhances the accuracy and applicability of research findings. Iowa is also recognized for its innovative research environment and its cutting-edge medical advancements, driven by leading institutions such as the University of Iowa.

By choosing to participate in a clinical trial in Iowa, participants contribute to critical medical research while benefiting from a well-established and supportive clinical research infrastructure that promotes breakthroughs in patient care and treatment.

Common conditions studied in Iowa

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Iowa